How We Get Go to Market Materials Approved Faster
A modernized approach designed to accelerate materials to market by 300%.
The Business Opportunity
A global pharma organization needed a new solution to speed up the go to market materials for drug launches. The existing process was cumbersome and inefficient. In order to bring the best treatments to patients as quickly as possible, the organization needed a faster way to get to market once the FDA approvals went through. This new approach needed to be streamlined and flawless. Additionally, there was not time to rebuild teams or reengineer approval platforms, the work needed to be done within the existing structure. Every minute impacted patients.
Inspired Consulting
We listened to the goals and objectives of our pharma client and knew something big had to change in the way of working. The client was continuously leaving opportunities on the table by not being able to get to market faster. In this transformational go to market program we leaned heavily into our decades of experience in pharma and regulatory. We brought in our top consulting expertise to develop a repeatable process within the existing confines of the existing team and platforms. Our team reimagined what a faster process could look like and outlined a roadmap on how to achieve it.
Meaningful Results
Ultimately our team was able to increase the time to market by 300% through expedited reviews, streamlined processes, removing unnecessary bottlenecks and working on tight SLAs. This meant that more patients could have access to the new drugs, faster. Ultimately helping to save lives and meet the objectives of our client. We developed tight SLAs customized to the clients’ specific goals. Our experts devised ways to work expeditiously within the existing approval platforms and developed detailed processes help to streamline approvals, reduce mistakes and get go to market materials out faster.
Why We Loved This Project
We loved this project because we made a direct impact on patient lives, our client and their goal to get drug launch marketing materials out faster. Our client was collaborative and embraced new changes that allowed us to be able to reach our collective goals.